enGene Holdings Inc.
ENGN$655M
Small CapNASDAQBiological Products, (No Diagnostic Substances)🇺🇸North AmericaSAINT-LAURENT
Drugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Jun 30, 2026
15wMarket Overview
Stock performance and key metrics
ENGN News
Catalyst Timeline
1 upcoming, 1 past
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
EG-70 (phase 1) | Phase 2 | Superficial Bladder Cancer | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply